Breaking News Instant updates and real-time market news.

AA

Alcoa

$25.00

0.46 (1.87%)

, CTL

CenturyLink

$10.73

0.21 (2.00%)

09:55
05/14/19
05/14
09:55
05/14/19
09:55

Early notable gainers among liquid option names on May 14th

Notable gainers among liquid option names this morning include Alcoa (AA) $25.20 +0.66, CenturyLink (CTL) $10.79 +0.27, Transocean (RIG) $7.24 +0.18, Legg Mason (LM) $34.06 +0.83, and Autodesk (ADSK) $168.95 +4.07.

AA

Alcoa

$25.00

0.46 (1.87%)

CTL

CenturyLink

$10.73

0.21 (2.00%)

RIG

Transocean

$7.26

0.2 (2.83%)

LM

Legg Mason

$34.00

0.745 (2.24%)

ADSK

Autodesk

$167.98

3.05 (1.85%)

  • 14

    May

  • 22

    May

  • 23

    May

  • 12

    Jun

AA Alcoa
$25.00

0.46 (1.87%)

04/18/19
JPMS
04/18/19
NO CHANGE
Target $52
JPMS
Overweight
Alcoa estimates and price target lowered at JPMorgan
JPMorgan analyst Michael Gambardella reduced his estimates for Alcoa to reflect lower earnings estimates for the company's Aluminum segment. However, Gambardella expects Alcoa's earnings to "take a step up" in the second half of 2019 and believes its efforts to improve operational performance and optimize its portfolio should continue to drive value this year and next. He lowered his price target for the shares to $52 from $60 but keeps an Overweight rating on the name. Gambardella does not see much further downside in alumina or aluminum prices, which he says creates an attractive risk/reward for Alcoa shares.
04/22/19
GABE
04/22/19
UPGRADE
GABE
Buy
Alcoa upgraded to Buy from Hold at Gabelli
04/22/19
04/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IPG Photonics (IPGP) upgraded to Buy from Neutral at BofA/Merrill. 2. Caleres (CAL) upgraded to Buy from Hold at Needham with analyst Rick Patel saying that his recent meeting with its CEO and CFO have given him an added confidence about the FY19 EPS guidance being "achievable and likely beatable." 3. Viavi (VIAV) upgraded to Neutral from Underweight at JPMorgan with analyst Samik Chatterjee saying the "buildup of industry tailwinds" in the form of 5G network deployments as well as fiber densification and adoption of 3D Sensing should drive medium-term growth above expectations. 4. Alcoa (AA) upgraded to Buy from Hold at Gabelli. 5. Lam Research (LRCX) upgraded to Buy from Neutral at B. Riley FBR with analyst Craig Ellis saying he sees "increasingly visible recent signs" of a cyclical trough in Q1. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
BMOC
04/18/19
NO CHANGE
Target $40
BMOC
Outperform
Alcoa price target lowered to $40 from $45 at BMO Capital
BMO Capital analyst David Gagliano lowered his price target on Alcoa to $40 after its Q1 earnings miss, saying that the results were weighed down by the 20% sequential decline in alumina prices. The analyst also lowers his FY19 EPS view by $1.01 to 78c on lower price assumptions but keeps his Outperform rating longer term, saying the stock offers a "favorable risk/reward for exposure to aluminum that is poised to rebound over the next 12 months."
CTL CenturyLink
$10.73

0.21 (2.00%)

02/26/19
02/26/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Caterpillar (CAT) downgraded to Sell from Buy at UBS by analyst Steven Fisher, who believes believes ~55% of Caterpillar's end markets will peak in 2019, pressuring revenue and margins in 2020 as demand declines. Continued growth in mining and share buybacks will not be enough to offset headwinds in construction and oil and gas, he said. 2. Foot Locker (FL) downgraded to Hold from Buy at Pivotal Research by analyst Mitchel Kummetz, who sees a less favorable risk/reward into the company's Q4 results on March 1. The analyst expects "solid" Q4 results but believes the company's Q1 is likely off to a slow start. An easy two-year comparison may not be enough for Foot Locker to generate solid Q1 same-store-sales, as the quarter is likely off to a slow start on delayed/reduced tax refunds, he said. 3. Windstream (WIN) downgraded to Underperform from Market Perform at Wells Fargo by analyst Jennifer Fritzsche to reflect the company's filing for Chapter 11 restructuring and uncertainty surrounding the short to medium term operations and financing challenges. 4. Palo Alto Networks (PANW) downgraded to Market Perform from Outperform at Northland by analyst Robert Breza, who stated that he expects upside to Q2 revenue and EPS given the company's track record of earnings beats, but he also expects EPS to be guided down as the company invests for growth while absorbing the Demisto acquisition. 5. CenturyLink (CTL) downgraded to Neutral from Buy at BofA/Merrill by analyst David Barden, who said he learned that the dividend cut was based on leverage, maturities, and the state of the bond market, not any fundamental change in the business, revenue fixes are being taken but the top line will not inflect this year, and no structural changes are underway at this time. The analyst came away more confident about underlying trends, but believes investors are more focused on near-term revenue and believes Q1 consensus estimates are too high, setting up for poor stock performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/26/19
BOFA
02/26/19
DOWNGRADE
BOFA
Neutral
CenturyLink downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst David Barden downgraded CenturyLink to Neutral and maintained a $14 price target ahead of Q1 results following recent management meetings. Barden learned that the dividend cut was based on leverage, maturities, and the state of the bond market, not any fundamental change in the business, revenue fixes are being taken but the top line will not inflect this year, and no structural changes are underway at this time. The analyst came away more confident about underlying trends, but believes investors are more focused on near-term revenue and believes Q1 consensus estimates are too high, setting up for poor stock performance.
05/09/19
SBSH
05/09/19
UPGRADE
SBSH
Neutral
CenturyLink upgraded to Neutral on cash flow, cost cutting at Citi
As previously reported, Citi analyst Michael Rollins upgraded CenturyLink (CTL) to Neutral from Sell. While he said the company reported "another mixed quarter" and he thinks the pace of revenue decline should continue to depress the multiple, the company's "aggressive" cost cutting, cash flow and dividend yield should provide downside support, Rollins tells investors. He remains cautious on whether CenturyLink can create value by separating its consumer business, he added. Rollins recommends that investors seeking dividends in Telco buy AT&T (T) and Verizon (VZ) instead.
05/09/19
SBSH
05/09/19
UPGRADE
SBSH
Neutral
CenturyLink upgraded to Neutral from Sell at Citi
Citi analyst Michael Rollins upgraded CenturyLink to Neutral from Sell.
RIG Transocean
$7.26

0.2 (2.83%)

05/01/19
RBCM
05/01/19
NO CHANGE
Target $30
RBCM
Outperform
Transocean added to 'Global Energy Best Ideas List' at RBC Capital
RBC Capital analyst Kurt Hallead kept his Outperform rating and $30 price target on Transocean but added the stock to his RBC Global Energy Best Ideas List after its 10% price decline yesterday. The analyst contends that the offshore drilling cycle is gaining momentum as seen in the "increased utilization and pricing for a variety of assets" across several regions. Hallead is also positive on Transocean's inventory of deepwater rigs as well as its "ample liquidity" to pay off the debt maturing in the next few years.
02/20/19
02/20/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) resumed with a Neutral from Sell at Citi with analyst Andrew Baum saying the recent pullback in the stock, along with the 5%-8% 2019-2021 consensus estimate reductions, gives him the opportunity to close his Sell rating. 2. Transocean (RIG) and Diamond Offshore (DO) were upgraded to Overweight from Underweight at Barclays. 3. American Axle (AXL) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy citing progress with restructuring, GM's (GM) truck cycle, and balance sheet deleveraging. 4. Credit Suisse (CS) upgraded to Hold from Sell at Berenberg. 5. Ipsen (IPSEY) upgraded to Neutral from Sell at Goldman Sachs with analyst Diana Na citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/11/19
GSCO
03/11/19
INITIATION
GSCO
Goldman Sachs starts 19 in Oilfield Services, top pick is Baker Hughes
Goldman Sachs analyst Angie Sedita last night initiated coverage of 19 names in the Oilfield Services & Equipment space. The analyst sees three themes: A slow recovery in the offshore markers benefiting both offshore drilling and subsea, U.S. frac activity outpacing land drilling over the near-term, and a a surge of LNG projects moving forward benefiting companies exposed to those trends. Valuations are at the low end of historical ranges, says the analyst, who expects annual earnings growth of 15%-30% through 2021 for the group. Sedita's top pick is Baker Hughes (BHGE), a stock she started with a Conviction Buy rating. Her top Sell is Diamond Offshore (DO). Along with Baker Hughes, the analyst put Buy ratings on Halliburton (HAL), Schlumberger (SLB), Transocean (RIG), TechnipFMC (FTI), Nine Energy Services (NINE) and ProPetro Holding (PUMP). Along with Diamond Offshore, Sedita also put a Sell rating on RPC, Inc. (RES).
03/10/19
GSCO
03/10/19
INITIATION
Target $11
GSCO
Buy
Transocean initiated with a Buy at Goldman Sachs
Goldman Sachs started Transocean with a Buy rating and $11 price target.
LM Legg Mason
$34.00

0.745 (2.24%)

02/05/19
SBSH
02/05/19
UPGRADE
SBSH
Buy
Legg Mason upgraded to Buy from Neutral at Citi
Citi analyst Citi analyst William Katz upgraded Legg Mason to Buy.
05/14/19
RBCM
05/14/19
NO CHANGE
Target $39
RBCM
Outperform
Legg Mason price target raised to $39 from $35 at RBC Capital
RBC Capital analyst Kenneth Lee raised his price target on Legg Mason to $39 to reflect the upward drift in its peer group multiples since his last revision. The analyst also notes that the company's Q4 earnings were "in-line" and reduces his FY20 EPS outlook by 12c to $3.25 given his expected impact from its strategic restructuring and assumption of no buybacks this year, but keeps his Outperform rating on Legg Mason shares.
02/05/19
02/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Covanta (CVA) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Lee saying he expects near-term U.K. project pipeline catalysts to highlight the company's medium-to-long term growth potential. 2. Booking Holdings (BKNG) upgraded to Buy from Hold at Deutsche Bank with analyst Lloyd Walmsley saying Booking's room night growth can accelerate in 2019 as the company "leans back into marketing channels," and this can drive multiple expansion. 3. Regenxbio (RGNX) upgraded to Strong Buy from Outperform at Raymond James with analyst Reni Benjamin saying his recent talks with management gave him added information on RGX-314 in patients with wet age-related macular degeneration and an update on the company's other gene therapy programs. 4. Legg Mason (LM) upgraded to Buy from Neutral at Citi. 5. Nine Energy Services (NINE) upgraded to Buy from Hold at Tudor Pickering. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/05/19
WELS
02/05/19
NO CHANGE
Target $34
WELS
Outperform
Legg Mason price target raised to $34 from $29 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for Legg Mason to $34 from $29, while reiterating an Outperform rating on the shares. The company's Q3 was quite noisy because of various charges, but the bigger news was the unveiled plan to implement a new operating platform expected to produce material cost savings, he notes.
ADSK Autodesk
$167.98

3.05 (1.85%)

04/11/19
04/11/19
INITIATION
Target $200

Buy
Autodesk initiated with a Buy at Mizuho
As previously reported, Mizuho analyst Matthew Broome initiated Autodesk with a Buy rating and a price target of $200. The analyst is positive on the company building its value proposition "beyond its traditional design base into lifecycle management, construction, and generative design", while expanding penetration with current customers and the overall total addressable market. Broome believes that Autodesk has multiple catalysts given its "strong upsell opportunities to Industry Collections, an improving direct sales mix, and more targeted digital marketing."
04/12/19
04/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Redfin (RDFN) initiated with an Outperform at Wedbush. 2. Autodesk (ADSK) initiated with a Buy at Mizuho. 3. Upwork (UPWK) initiated with a Buy at BTIG. 4. Otter Tail (OTTR) initiated with a Buy at Maxim. 5. Disney (DIS) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/19
MZHO
04/11/19
INITIATION
Target $120
MZHO
Autodesk initiated with a Buy at Mizuho
04/10/19
KEYB
04/10/19
INITIATION
Target $196
KEYB
Overweight
Autodesk resumed with an Overweight at KeyBanc
KeyBanc analyst Jason Celino resumed coverage of Autodesk with an Overweight rating and a $196 price target. The analyst is confident that Autodesk has ample growth drivers to power its next leg of growth.

TODAY'S FREE FLY STORIES

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

TEAM

Atlassian

$129.57

2.33 (1.83%)

16:11
05/24/19
05/24
16:11
05/24/19
16:11
Hot Stocks
Atlassian co-CEOs adopt new 10b5-1 trading plans »

Atlassian announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Jun

HIBB

Hibbett Sports

$23.90

4.06 (20.46%)

16:10
05/24/19
05/24
16:10
05/24/19
16:10
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MYOV

Myovant Sciences

$12.44

-0.415 (-3.23%)

16:09
05/24/19
05/24
16:09
05/24/19
16:09
Earnings
Myovant Sciences reports Q4 EPS ($1.07), consensus ($1.02) »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:06
05/24/19
05/24
16:06
05/24/19
16:06
Periodicals
TD Bank's Masrani says trade tensions put confidence at risk, Bloomberg says »

In an interview with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$71.06

1.07 (1.53%)

16:02
05/24/19
05/24
16:02
05/24/19
16:02
Recommendations
Copart analyst commentary  »

Outlook for Copart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

PFE

Pfizer

$41.96

0.04 (0.10%)

16:01
05/24/19
05/24
16:01
05/24/19
16:01
Hot Stocks
Pfizer says Phase 3 study of LYRICA did not meet primary endpoint »

Pfizer announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IMMR

Immersion

$7.69

-0.03 (-0.39%)

15:55
05/24/19
05/24
15:55
05/24/19
15:55
Options
Immersion put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.